Onconano Medicine, Inc.
Onconano Medicine, Inc. is a biotech company in Dallas, United States, founded in 2017. It has raised $100.8M across 3 rounds, most recently a $50.0M Series B in June 2025.
OncoNano
- Headquarters
- Dallas, Texas
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- onconano.com
- Total Funding
- $100.8M
- Last Round
- $50.0M Series BJun 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
OncoNano Medicine is a clinical-stage oncology company developing nanotechnology-enabled cancer therapeutics based on its proprietary ON-BOARD platform, which exploits the acidic tumor microenvironment to maximize intratumoral drug delivery. A spinout of UT Southwestern Medical Center, the Dallas-based company is advancing a pipeline including ONM-501, a dual-acting STING agonist in Phase 1 trials, and pegsitacianine, a fluorescent imaging probe for tumor-guided surgery.
Summary
It lists 11–50 employees. It has raised $100.8M in total across 3 rounds, most recently a $50.0M Series B round in Jun 2025. Investors include Advantech Capital.
Funding History
Jun 2025
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/onconano-medicine-inc"><img src="https://indexed.vc/api/badge/company/onconano-medicine-inc" alt="Onconano Medicine, Inc. on Indexed.vc" width="260" height="76" /></a>